biomarker discovery
Kairos Pharma, PreCheck Health Services to Develop CDx for Prostate, Lung Cancer Drug
PreCheck will help the biopharma firm confirm and validate biomarkers previously identified in early-phase trials for companion diagnostic use.
City of Hope, Institute for Follicular Lymphoma Innovation Partner on $2M Research Program
The three-year effort will use DNA profiling, proteomics, and machine learning techniques to explore potential triggers of spontaneous remission.
Concr Exploring Biomarkers of Response to Neoadjuvant TNBC Therapy
The firm will use its AI-based platform to create "digital twins" of TNBC patients and predict neoadjuvant treatment response.
BostonGene, Saga University Partner to Study Lung Cancer Immunotherapy Biomarkers
Investigators will conduct a study analyzing features of the tumor microenvironment in EGFR-positive patients, exploring response and resistance mechanisms.
Volastra Therapeutics Inks Two New Deals to ID Biomarkers for KIF18A Inhibitor Patient Selection
The firm's new predictive biomarker-focused collaborations with Function Oncology and Tailor Bio build on a 2020 deal with Microsoft.